HPLC Measurement of MDMA Content in Ecstasy Tablets Available in the Black Market of West Azerbaijan Province, Northwestern Iran

سال انتشار: 1393
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 489

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PJMT-3-4_006

تاریخ نمایه سازی: 23 مهر 1398

چکیده مقاله:

Background:Ecstasy, mainly composed of 3,4-methylenedioxymethamphetamine (MDMA), is one of the most popular addictive synthetic drugs. This study was aimed to investigate the amount of MDMA in the ecstasy tablets seized in West Azerbaijan province, northwest Iran and also to assess the relationship between the physicochemical and morphological characteristics of the tablets. Methods: MDMA content of ecstasy tablets was analyzed using high-performance liquid chromatography method. Flow rate was 3 mL/min and mobile phase consisted of a mixture of acetonitrile and water containing triethylamine (pH = 3.2). The fluorescence spectrophotometer detector set at an excitation and emission wavelength of 220 and 306 nm, respectively. The retention time of ecstasy on this system was 2.2 minutes. The calibration curve was linear (R2= 0.999) over the concentrations ranging from 0.2 to 2 µg/ml. The limit of detection and the limit of quantitation were found to be 0.06 µg/L and 0.19 µg/L, respectively with six times repetition. Results: In this study, 85 ecstasy tablets were analyzed. Mean weight of the tablets was 275.6 ± 70.4 (range: 158.5-403.3) mg. Mean MDMA content of the tablets was 30.53 ± 23.23 (range: 0.05-70.7) mg. The tablets were classified into 8 groups based on their morphological features (color and logo). Considering the tablet groups, physicochemical features of the tablets (weight, MDMA content, and MDMA to weight ratio) were significantly different (P < 0.001). Correlation analysis showed that the MDMA content and weight of tablets were significantly correlated (P = 0.04). Conclusion: There is variability in the physicochemical properties of ecstasy tablets available in the black market for illicit drugs in northwest Iran. This variability may potentially put abusers at increased risk of overdose due to inadvertent excess ingestion of the tablets to achieve desired effects and also experiencing more harm due to tablets adulterants.

کلیدواژه ها:

Amphetamines ، High Pressure Liquid Chromatography ، Iran ، N-Methyl-3 ، 4-methylenedioxyamphetamine ، Street Drugs

نویسندگان

Reza Ghafari

Department of Basic Sciences, Science and Research Branch, Islamic Azad University, Hesarak, Tehran, Iran

Amir Heydari

Department of Pharmacology, Faculty of Pharmacy, Urmia University of Medical Science, Urmia, Iran

Mohammad Reza Vardast

Department of Medicinal Chemistry, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran

Azam Akbari

Department of Medicinal Chemistry, Center for Cellular and Molecular Research, Urmia University of Medical Sciences, Urmia, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann ...
  • Amiri ZM, Shakib AJ, Moosavi AK. Prevalence and risk factors ...
  • Kelleher C, Christie R, Lalor K, Fox J, Bowden M, ...
  • Maxwell JC, Rutkowski BA. The prevalence of methamphetamine and amphetamine ...
  • Afshari R. Non-medical Use of Medications in Middle and Low ...
  • Afshari R, Monzavi SM. Poisoning with illegal substances and opioids. ...
  • Heydari A, Yeo KR, Lennard MS, Ellis SW, Tucker GT, ...
  • Gudelsky GA, Yamamoto BK. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral ...
  • Kalant H. The pharmacology and toxicology of ecstasy (MDMA) and ...
  • Rogers G, Elston J, Garside R, Roome C, Taylor R, ...
  • Taurah L, Chandler C, Sanders G. Depression, impulsiveness, sleep, and ...
  • Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) ...
  • Raisjouyan Z, Talebi M, Ghasimi Shahgaldi F, Abdollahian E. Investigating ...
  • Wood DM, Stribley V, Dargan PI, Davies S, Holt DW, ...
  • Sherlock K, Wolff K, Hay AW, Conner M. Analysis of ...
  • Bell SE, Burns DT, Dennis AC, Matchett LJ, Speers JS. ...
  • Cole JC, Bailey M, Sumnall HR, Wagstaff GF, King LA. ...
  • Khajeamiri AR, Kobarfard F, Ahmadkhaniha R, Mostashari G. Profiling of ...
  • Shetab Boushehri SV, Tamimi M, Kebriaeezadeh A. Quantitative determination of ...
  • Palhol F, Lamoureux C, Chabrillat M, Naulet N. 15N/14N isotopic ...
  • Teng SF, Wu SC, Liu C, Li JH, Chien CS. ...
  • Parrott AC. Is ecstasy MDMA A review of the proportion ...
  • Tanner-Smith EE. Pharmacological content of tablets sold as ecstasy : ...
  • Cole C, Jones L, McVeigh J, Kicman A, Syed Q, ...
  • Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke ...
  • نمایش کامل مراجع